X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs UNICHEM LAB - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS UNICHEM LAB J.B.CHEMICALS/
UNICHEM LAB
 
P/E (TTM) x 14.8 29.1 50.8% View Chart
P/BV x 2.3 3.1 76.3% View Chart
Dividend Yield % 0.2 0.6 26.7%  

Financials

 J.B.CHEMICALS   UNICHEM LAB
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
UNICHEM LAB
Mar-16
J.B.CHEMICALS/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs318334 95.2%   
Low Rs200174 114.7%   
Sales per share (Unadj.) Rs148.0146.9 100.7%  
Earnings per share (Unadj.) Rs19.111.9 160.5%  
Cash flow per share (Unadj.) Rs23.916.2 147.9%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Dividend yield (eoy) %0.20.8 24.5%  
Book value per share (Unadj.) Rs128.9105.1 122.7%  
Shares outstanding (eoy) m84.8290.84 93.4%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.71.7 101.2%   
Avg P/E ratio x13.621.4 63.5%  
P/CF ratio (eoy) x10.815.7 68.9%  
Price / Book Value ratio x2.02.4 83.1%  
Dividend payout %2.616.8 15.6%   
Avg Mkt Cap Rs m21,95123,073 95.1%   
No. of employees `0002.75.7 48.2%   
Total wages/salary Rs m1,8412,558 72.0%   
Avg. sales/employee Rs Th4,590.92,352.5 195.1%   
Avg. wages/employee Rs Th673.4450.9 149.4%   
Avg. net profit/employee Rs Th592.1190.4 310.9%   
INCOME DATA
Net Sales Rs m12,55113,346 94.0%  
Other income Rs m542192 282.2%   
Total revenues Rs m13,09313,538 96.7%   
Gross profit Rs m2,0551,639 125.4%  
Depreciation Rs m412390 105.7%   
Interest Rs m9629 332.3%   
Profit before tax Rs m2,0881,412 147.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m469293 160.3%   
Profit after tax Rs m1,6191,080 149.8%  
Gross profit margin %16.412.3 133.3%  
Effective tax rate %22.520.7 108.4%   
Net profit margin %12.98.1 159.3%  
BALANCE SHEET DATA
Current assets Rs m7,7785,979 130.1%   
Current liabilities Rs m4,3582,432 179.2%   
Net working cap to sales %27.226.6 102.5%  
Current ratio x1.82.5 72.6%  
Inventory Days Days5563 86.7%  
Debtors Days Days8060 132.5%  
Net fixed assets Rs m5,7136,403 89.2%   
Share capital Rs m170182 93.3%   
"Free" reserves Rs m10,5479,293 113.5%   
Net worth Rs m10,9379,548 114.5%   
Long term debt Rs m0230 0.0%   
Total assets Rs m15,57412,843 121.3%  
Interest coverage x22.850.0 45.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.81.0 77.6%   
Return on assets %11.08.6 127.5%  
Return on equity %14.811.3 130.8%  
Return on capital %20.014.3 139.3%  
Exports to sales %48.729.2 166.7%   
Imports to sales %7.16.3 111.6%   
Exports (fob) Rs m6,1153,900 156.8%   
Imports (cif) Rs m889847 105.0%   
Fx inflow Rs m6,1694,356 141.6%   
Fx outflow Rs m1,2851,162 110.6%   
Net fx Rs m4,8843,194 152.9%   
CASH FLOW
From Operations Rs m1,3971,119 124.8%  
From Investments Rs m-320-853 37.5%  
From Financial Activity Rs m-1,196-334 357.8%  
Net Cashflow Rs m-102-68 149.8%  

Share Holding

Indian Promoters % 55.4 50.1 110.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 15.1 22.5%  
FIIs % 3.9 3.0 130.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 31.7 116.7%  
Shareholders   30,437 20,176 150.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SHASUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  WYETH LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Mr Modi Providing Impetus to Defense Industry and Key Stocks in Action Today(Pre-Open)

Addressing the Uttar Pradesh Investors Summit, Mr. Modi announced the creation of a defense industrial corridor in Bundelkhand.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 21, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - DISHMAN PHARMA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS